发明名称 THERAPEUTIC AGENT FOR MENTAL DISORDER SYMPTOM INVOLVED IN CEREBROVASCULAR DISEASE
摘要 PURPOSE: To obtain a therapeutic agent useful for mental disorder symptoms involved in cerebrovascular diseases (e.g. problem behaviors, emotional disorders), containing, as the essential ingredient, a compound capable of blocking both serotonin-2 receptor and dopamine D2 receptor. CONSTITUTION: This therapeutic agent contains, as the essential ingredient, a compound capable of blocking both serotonin-2 receptor and dopamine D2 receptor, pref. a compound selected from SM-9018 of formula I, risperidone of formula II, diprasidone hydrochloride (CP-88059-01) of formula III, ocaperidone of formula IV (R-79598), etc., esp. pref. SM-9018 of formula I. The permissible effective amount of the compound per adult a day is pref. about 0.05-500 (esp. pref. about 0.2-50)mg, for example, in the case of SM-9018 for oral administration, pref. 0.5-10mg a day per adult.
申请公布号 JPH08193033(A) 申请公布日期 1996.07.30
申请号 JP19950003191 申请日期 1995.01.12
申请人 SUMITOMO PHARMACEUT CO LTD 发明人 OTOMO HIDEKAZU
分类号 C07D295/20;A61K31/00;A61K31/40;A61K31/407;A61K31/44;A61K31/4427;A61K31/444;A61K31/445;A61K31/454;A61K31/495;A61K31/496;A61K31/505;A61K31/519;A61K31/551;A61K45/00;A61P9/08;A61P9/10;A61P25/18;A61P25/20;A61P25/22;A61P25/24;A61P25/26;A61P25/28;A61P43/00;C07D221/04;C07D401/14;C07D413/04;C07D417/12;C07D471/04;C07D491/044 主分类号 C07D295/20
代理机构 代理人
主权项
地址
您可能感兴趣的专利